Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 4.05168 | 67 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 4.05368 | 67 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 4.04676 | 67 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 4.21046 | 68 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.99773 | 66 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.06491 | 67 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.2834 | 69 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.0215 | 66 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 4.13366 | 68 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.03458 | 67 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 4.02275 | 67 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 4.02433 | 67 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.04738 | 67 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.03446 | 67 |